Market closedNon-fractional

Asensus Surgical/ASXC

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Asensus Surgical

Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

Ticker

ASXC

Sector

Healthcare

Trading on

AMEX

Industry

Health Care Equipment and Supplies

Headquarters

Durham, United States

Employees

208

Asensus Surgical Metrics

BasicAdvanced
$92M
Market cap
-
P/E ratio
-$0.31
EPS
1.43
Beta
-
Dividend rate
$92M
1.43
0.998
0.449
33.784
41.892
-67.39%
-169.75%
9.998
7.07
7.73
-1.433
24.68%
-7.83%
23.26%
-16.52%

What the Analysts think about Asensus Surgical

Analyst Ratings

Majority rating from 2 analysts.
Hold

Asensus Surgical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-2,036.36% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.1M
-79.63%
Net income
-$22M
30.23%
Profit margin
-2,036.36%
539.34%

Asensus Surgical Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 60.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.09
-$0.07
-$0.06
-$0.08
-
Expected
-$0.08
-$0.07
-$0.08
-$0.05
-$0.06
Surprise
12.50%
0.00%
-25.00%
60.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Asensus Surgical stock?

Asensus Surgical (ASXC) has a market cap of $92M as of July 14, 2024.

What is the P/E ratio for Asensus Surgical stock?

The price to earnings (P/E) ratio for Asensus Surgical (ASXC) stock is 0 as of July 14, 2024.

Does Asensus Surgical stock pay dividends?

No, Asensus Surgical (ASXC) stock does not pay dividends to its shareholders as of July 14, 2024.

When is the next Asensus Surgical dividend payment date?

Asensus Surgical (ASXC) stock does not pay dividends to its shareholders.

What is the beta indicator for Asensus Surgical?

Asensus Surgical (ASXC) has a beta rating of 1.43. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Asensus Surgical stock

Buy or sell Asensus Surgical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing